Drug Type Small molecule drug |
Synonyms NAMPT activators(Sironax) |
Target |
Action activators |
Mechanism NAMPT activators(Nicotinamide phosphoribosyltransferase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuromuscular Diseases | Phase 1 | Australia | 27 Nov 2024 | |
Cardiovascular Diseases | Preclinical | China | 15 Apr 2024 | |
Inflammation | Preclinical | China | 15 Apr 2024 | |
Kidney Diseases | Preclinical | China | 15 Apr 2024 | |
Mitochondrial Diseases | Preclinical | China | 15 Apr 2024 | |
Neoplasms | Preclinical | China | 15 Apr 2024 | |
Neurodegenerative Diseases | Preclinical | China | 15 Apr 2024 |